Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on August 13, 2007

Hypertension. 2007
Published online before print August 13, 2007, doi: 10.1161/HYPERTENSIONAHA.107.089748
A more recent version of this article appeared on October 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
50/4/663    most recent
HYPERTENSIONAHA.107.089748v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cao, X.
Right arrow Articles by Kreulen, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cao, X.
Right arrow Articles by Kreulen, D. L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*OXYGEN
Related Collections
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Other etiology
Right arrowRelated Article

Submitted on February 28, 2007
Revised on March 19, 2007

Differential Regulation of NADPH Oxidase in Sympathetic and Sensory Ganglia in Deoxycorticosterone Acetate–Salt Hypertension

Xian Cao; Xiaoling Dai; Lindsay M. Parker; and David L. Kreulen*

From the Departments of Physiology (X.C., L.M.P., D.L.K.), Neurology and Ophthalmology (D.L.K.), Pharmacology and Toxicology (X.D.), and Neuroscience Program (X.C., X.D., D.L.K.), Michigan State University, East Lansing.

* To whom correspondence should be addressed. E-mail: dkreulen{at}msu.edu.

Abstract—We demonstrated recently that superoxide anion levels are elevated in prevertebral sympathetic ganglia of deoxycorticosterone acetate–salt hypertensive rats and that this superoxide anion is generated by reduced nicotinamide-adenine dinucleotide phosphate oxidase. In this study we compared the reduced nicotinamide-adenine dinucleotide phosphate oxidase enzyme system of dorsal root ganglion (DRG) and sympathetic celiac ganglion (CG) and its regulation in hypertension. The reduced nicotinamide-adenine dinucleotide phosphate oxidase activity of ganglion extracts was measured using fluorescence spectrometry of dihydroethidine; the activity in hypertensive dorsal root ganglion was 34% lower than in normotensive DRG. In contrast, activity was 79% higher in hypertensive CG than normotensive CG. mRNA for the oxidase subunits NOX1, NOX2, NOX4, p47phox, and p22phox were present in both CG and DRG; mRNA for NOX4 was significantly higher in CG than in DRG. The levels of mRNA and protein expression of the membrane-bound catalytic subunit p22phox and of the regulatory subunits p47phox and Rac-1 were measured in CG and DRG in normotensive and hypertensive rats. p22phox mRNA and protein expression was greater in CG of hypertensive rats but not in DRG. Compared with normotensive controls, p47phox mRNA and protein, as well as Rac-1 protein, were significantly decreased in hypertensive DRG but not in CG. Immunohistochemical staining of p47phox showed translocation from cytoplasm to membrane in hypertensive CG but not in hypertensive DRG. This suggests that reduced nicotinamide-adenine dinucleotide phosphate oxidase activation in sympathetic neurons and sensory neurons is regulated in opposite directions in hypertension. This differential regulation may contribute to unbalanced vasomotor control and enhanced vasoconstriction in the splanchnic circulation.


Key words: superoxide • sympathetic ganglia • sensory ganglia • NADPH oxidase • rat • hypertension


Related Article:

The Continuing Saga of Neuronal Oxidative Stress in Hypertension: Nox, Nox–Who’s There, and Where?
Mark W. Chapleau
Hypertension 2007 50: 600-602. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
M. W. Chapleau
The Continuing Saga of Neuronal Oxidative Stress in Hypertension: Nox, Nox Who's There, and Where?
Hypertension, October 1, 2007; 50(4): 600 - 602.
[Full Text] [PDF]